サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1360339

リポソームドラッグデリバリー市場：世界の業界分析、規模、シェア、成長、動向、および予測、2023年～2031年

Liposome Drug Delivery Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

出版日
ページ情報
英文 180 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.76円
リポソームドラッグデリバリー市場：世界の業界分析、規模、シェア、成長、動向、および予測、2023年～2031年
出版日: 2023年08月10日
発行: Transparency Market Research
ページ情報: 英文 180 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

リポソームドラッグデリバリー市場- レポートの範囲

世界のリポソームドラッグデリバリー市場に関するTMRのレポートは、過去と現在の成長動向、および2023年から2031年の予測期間中に市場の指標の貴重な洞察を得る機会を研究しています。このレポートは、世界のリポソームドラッグデリバリーの収益を提供します。 2023年を基準年、2031年を予測年とみなして、2017年から2031年の期間の市場を分析します。レポートは、2023年から2031年までの世界のリポソームドラッグデリバリー市場の複合年間成長率（CAGR %）も提供します。

このレポートは広範な調査を経て作成されました。1次調査では、調査活動の大部分が行われ、アナリストが主要なオピニオンリーダー、業界リーダー、オピニオンメーカーにインタビューを実施しました。2次調査には、リポソームドラッグデリバリー市場を理解するために、主要企業の製品文献、年次報告書、プレスリリース、および関連文書を参照することが含まれていました。

市場スナップショット
2023年の市場価値 47億米ドル
2031年の市場価値 100億米ドル
CAGR 8.5%

このレポートは、世界のリポソームドラッグデリバリー市場の競合情勢を詳しく掘り下げています。世界のリポソームドラッグデリバリー市場で活動している主要企業が特定され、これらのそれぞれがさまざまな属性の観点からプロファイルされています。会社概要、財務状況、最近の動向、 SWOTは、このレポートで紹介されている世界のリポソームドラッグデリバリー市場の企業の属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界市場の分析と予測、2017～2031年

第5章 主要な洞察

  • 技術の進歩
  • 概要：システム
  • 規制シナリオ
  • COVID-19パンデミックによる業界への影響（バリューチェーンと短期・中期・長期的な影響）

第6章 世界市場分析と予測：リポソーム構造別

  • イントロダクションと定義
  • 主な発見と開発
  • 市場金額予測：リポソーム構造別、2017-2031
    • 単層リポソーム
      • 小さい
      • 大きい
    • 多重層リポソーム
    • その他
  • 市場魅力分析：リポソーム構造別

第7章 世界市場の分析と予測：製品別

  • イントロダクションと定義
  • 主な発見と開発
  • 市場金額予測：製品別、2017-2031
    • リポソームドキソルビシン
    • リポソームパクリタキセル
    • リポソームアムホテリシンB
    • その他
  • 市場魅力度分析：製品別

第8章 世界市場の分析と予測：テクノロジー別

  • イントロダクションと定義
  • 主な発見と開発
  • 市場金額予測：テクノロジー別、2017-2031
    • ステルスリポソーム技術
    • 非PEG化リポソーム技術
    • DepoFoamリポソーム技術
    • Lysolipid熱感受性リポソーム技術
  • 市場魅力分析：テクノロジー別

第9章 世界市場の分析と予測：用途別

  • イントロダクションと定義
  • 主な発見と開発
  • 市場金額予測：用途別、2017-2031
    • 真菌性疾患
    • がん治療
    • 疼痛管理
    • ウイルスワクチン
    • 光線力学療法
    • その他
  • 市場魅力分析：用途別

第10章 世界市場の分析と予測：エンドユーザー別

  • イントロダクションと定義
  • 主な発見と開発
  • 市場金額予測：エンドユーザー別、2017-2031
    • 病院
    • 専門センター
    • 外来手術センター
    • その他
  • 市場魅力度分析：エンドユーザー別

第11章 世界市場の分析と予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場魅力度分析：地域別

第12章 北米市場の分析と予測

第13章 欧州市場の分析と予測

第14章 アジア太平洋市場の分析と予測

第15章 ラテンアメリカ市場の分析と予測

第16章 中東およびアフリカ市場の分析と予測

第17章 競合情勢

  • 市場企業- 競合マトリックス：企業の階層および規模別
  • 市場シェア分析：企業別、2021年
  • 企業プロファイル
    • Johnson &Johnson Services, Inc.
    • Gilead Sciences, Inc.
    • Sun Pharmaceutical Industries Ltd.
    • Novartis AG
    • Teva Pharmaceutical Industries Ltd
    • Janssen Pharmaceuticals, Inc.
    • CELSION Corporation
    • Abbott
    • Ipsen Pharma
    • Spectrum Pharmaceuticals, Inc.
    • Takeda Pharmaceutical Company Limited
図表

List of Tables

  • Table 01: Pipeline Analysis - Liposome Drug Delivery Systems
  • Table 02: Clinically Marketed Liposome Drugs
  • Table 03: Regulations - Principle difference between U.S., EU and India
  • Table 04: Regulatory Scenario Assessment - Administrative Requirements
  • Table 05: Global Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Product, 2017-2027
  • Table 06: Global Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Technology, 2017-2027
  • Table 07: Global Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Application, 2017-2027
  • Table 08: Global Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Region, 2017-2027
  • Table 09: North America Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Country, 2017-2027
  • Table 10: North America Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Product, 2017-2027
  • Table 11: North America Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Technology, 2017-2027
  • Table 12: North America Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Application, 2017-2027
  • Table 13: Europe Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 14: Europe Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Product, 2017-2027
  • Table 15: Europe Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Technology, 2017-2027
  • Table 16: Europe Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Application, 2017-2027
  • Table 17: Asia Pacific Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 18: Asia Pacific Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Product, 2017-2027
  • Table 19: Asia Pacific Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Technology, 2017-2027
  • Table 20: Asia Pacific Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Application, 2017-2027
  • Table 21: Latin America Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 22: Latin America Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Product, 2017-2027
  • Table 23: Latin America Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Technology, 2017-2027
  • Table 24: Latin America Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Application, 2017-2027
  • Table 25: Middle East & Africa Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 26: Middle East & Africa Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Product, 2017-2027
  • Table 27: Middle East & Africa Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Technology, 2017-2027
  • Table 28: Middle East & Africa Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Application, 2017-2027

List of Figures

  • Figure 01: Global Liposome Drug Delivery Market Snapshot
  • Figure 02: Global Liposome Drug Delivery Market Value (US$ Mn), by Region, 2022 and 2031
  • Figure 03: Therapeutic applications of liposomes in drug delivery
  • Figure 04: Advantages of liposome drug delivery system
  • Figure 05: Global Liposome Drug Delivery Market Value (US$ Mn) and Y-o-Y (%) Forecast, 2017-2027
  • Figure 06: Global Liposome Drug Delivery Market Value Share, by Product, 2022
  • Figure 07: Global Liposome Drug Delivery Market Value Share, by Technology, 2022
  • Figure 08: Global Liposome Drug Delivery Market Value Share, by Application, 2022
  • Figure 09: Global Liposome Drug Delivery Market Value Share, by Region, 2022
  • Figure 10: Regulatory Approval Process - U.S.
  • Figure 11: Regulatory Approval Process - Europe
  • Figure 12: Regulatory Approval Process - India
  • Figure 13: Global Liposome Drug Delivery Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 14: Global Liposome Drug Delivery Market Attractiveness Analysis, by Product, 2017-2031
  • Figure 15: Global Liposome Drug Delivery Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Liposomal Doxorubicin, 2017-2027
  • Figure 16: Global Liposome Drug Delivery Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Liposomal Paclitaxel, 2017-2027
  • Figure 17: Global Liposome Drug Delivery Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Liposomal Amphotericin B, 2017-2027
  • Figure 18: Global Liposome Drug Delivery Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017-2027
  • Figure 19: Global Liposome Drug Delivery Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 20: Global Liposome Drug Delivery Market Attractiveness Analysis, by Technology, 2017-2031
  • Figure 21: Global Liposome Drug Delivery Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Stealth Liposome Technology, 2017-2027
  • Figure 22: Global Liposome Drug Delivery Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Non-PEGylated Liposome Technology, 2017-2027
  • Figure 23: Global Liposome Drug Delivery Market Revenue (US$ Mn) and Y-o-Y Growth (%), by DepoFoam Liposome Technology, 2017-2027
  • Figure 24: Global Liposome Drug Delivery Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 25: Global Liposome Drug Delivery Market Attractiveness Analysis, by Application, 2017-2031
  • Figure 26: Global Liposome Drug Delivery Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Fungal Diseases, 2017-2027
  • Figure 27: Global Liposome Drug Delivery Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Pain Management, 2017-2027
  • Figure 28: Global Liposome Drug Delivery Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cancer Therapy, 2017-2027
  • Figure 29: Global Liposome Drug Delivery Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Viral Vaccines, 2017-2027
  • Figure 30: Global Liposome Drug Delivery Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Photodynamic therapy, 2017-2027
  • Figure 31: Global Liposome Drug Delivery Market - Regional Outlook
  • Figure 32: Global Liposome Drug Delivery Market Value (US$ Mn) Forecast, 2017-2027
  • Figure 33: Global Liposome Drug Delivery Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 34: Global Liposome Drug Delivery Market Attractiveness Analysis, by Region, 2017-2031
  • Figure 35: North America Liposome Drug Delivery Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 36: North America Liposome Drug Delivery Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 37: North America Liposome Drug Delivery Market Attractiveness Analysis, by Country, 2017-2031
  • Figure 38: North America Liposome Drug Delivery Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 39: North America Liposome Drug Delivery Market Attractiveness Analysis, by Product, 2017-2031
  • Figure 40: North America Liposome Drug Delivery Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 41: North America Liposome Drug Delivery Market Attractiveness Analysis, by Technology, 2017-2031
  • Figure 42: North America Liposome Drug Delivery Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 43: North America Liposome Drug Delivery Market Attractiveness Analysis, by Application, 2017-2031
  • Figure 44: Europe Liposome Drug Delivery Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 45: Europe Liposome Drug Delivery Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 46: Europe Liposome Drug Delivery Market Attractiveness Analysis, by Country/Sub-region, 2017-2031
  • Figure 47: Europe Liposome Drug Delivery Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 48: Europe Liposome Drug Delivery Market Attractiveness Analysis, by Product, 2017-2031
  • Figure 49: Europe Liposome Drug Delivery Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 50: Europe Liposome Drug Delivery Market Attractiveness Analysis, by Technology, 2017-2031
  • Figure 51: Europe Liposome Drug Delivery Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 52: Europe Liposome Drug Delivery Market Attractiveness Analysis, by Application, 2017-2031
  • Figure 53: Asia Pacific Liposome Drug Delivery Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 54: Asia Pacific Liposome Drug Delivery Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 55: Asia Pacific Liposome Drug Delivery Market Attractiveness Analysis, by Country/Sub-region, 2017-2031
  • Figure 56: Asia Pacific Liposome Drug Delivery Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 57: Asia Pacific Liposome Drug Delivery Market Attractiveness Analysis, by Product, 2017-2031
  • Figure 58: Asia Pacific Liposome Drug Delivery Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 59: Asia Pacific Liposome Drug Delivery Market Attractiveness Analysis, by Technology, 2017-2031
  • Figure 60: Asia Pacific Liposome Drug Delivery Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 61: Asia Pacific Liposome Drug Delivery Market Attractiveness Analysis, by Application, 2017-2031
  • Figure 62: Latin America Liposome Drug Delivery Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 63: Latin America Liposome Drug Delivery Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 64: Latin America Liposome Drug Delivery Market Attractiveness Analysis, by Country/Sub-region, 2017-2031
  • Figure 65: Latin America Liposome Drug Delivery Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 66: Latin America Liposome Drug Delivery Market Attractiveness Analysis, by Product, 2017-2031
  • Figure 67: Latin America Liposome Drug Delivery Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 68: Latin America Liposome Drug Delivery Market Attractiveness Analysis, by Technology, 2017-2031
  • Figure 69: Latin America Liposome Drug Delivery Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 70: Latin America Liposome Drug Delivery Market Attractiveness Analysis, by Application, 2017-2031
  • Figure 71: Middle East & Africa Liposome Drug Delivery Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 72: Middle East & Africa Liposome Drug Delivery Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 73: Middle East & Africa Liposome Drug Delivery Market Attractiveness Analysis, by Country/Sub-region, 2017-2031
  • Figure 74: Middle East & Africa Liposome Drug Delivery Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 75: Middle East & Africa Liposome Drug Delivery Market Attractiveness Analysis, by Product, 2017-2031
  • Figure 76: Middle East & Africa Liposome Drug Delivery Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 77: Middle East & Africa Liposome Drug Delivery Market Attractiveness Analysis, by Technology, 2017-2031
  • Figure 78: Middle East & Africa Liposome Drug Delivery Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 79: Middle East & Africa Liposome Drug Delivery Market Attractiveness Analysis, by Application, 2017-2031
目次
Product Code: TMRGL28571

Liposome Drug Delivery Market - Scope of Report

TMR's report on the global liposome drug delivery market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global liposome drug delivery market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global liposome drug delivery market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the liposome drug delivery market.

Market Snapshot
Market Value in 2023US$ 4.7 Bn
Market Value in 2031US$ 10 Bn
CAGR8.5%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global liposome drug delivery market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global liposome drug delivery market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global liposome drug delivery market.

The report delves into the competitive landscape of the global liposome drug delivery market. Key players operating in the global liposome drug delivery market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global liposome drug delivery market profiled in this report.

Key Questions Answered in Global Liposome Drug Delivery Market Report:

  • What is the sales/revenue generated by liposome drug delivery across all regions during the forecast period?
  • What are the opportunities in the global liposome drug delivery market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Liposome Drug Delivery Market - Research Objectives and Research Approach

The comprehensive report on the global liposome drug delivery market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global liposome drug delivery market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global liposome drug delivery market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Liposome Drug Delivery Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Liposome Drug Delivery Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Technological Advancements
  • 5.2. Overview: Liposome Drug delivery Systems
  • 5.3. Regulatory Scenario
  • 5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Global Liposome Drug Delivery Market Analysis and Forecast, by Liposome Structure

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Liposome Structure, 2017-2031
    • 6.3.1. Unilamellar Liposomes
      • 6.3.1.1. Small
      • 6.3.1.2. Large
    • 6.3.2. Multilamellar liposomes
    • 6.3.3. Others
  • 6.4. Market Attractiveness Analysis, by Liposome Structure

7. Global Liposome Drug Delivery Market Analysis and Forecast, by Product

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Product, 2017-2031
    • 7.3.1. Liposomal Doxorubicin
    • 7.3.2. Liposomal Paclitaxel
    • 7.3.3. Liposomal Amphotericin B
    • 7.3.4. Others
  • 7.4. Market Attractiveness Analysis, by Product

8. Global Liposome Drug Delivery Market Analysis and Forecast, by Technology

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by Technology, 2017-2031
    • 8.3.1. Stealth Liposome Technology
    • 8.3.2. Non PEGylated Liposome Technology
    • 8.3.3. DepoFoam Liposome Technology
    • 8.3.4. Lysolipid Thermally Sensitive Liposome Technology
  • 8.4. Market Attractiveness Analysis, by Technology

9. Global Liposome Drug Delivery Market Analysis and Forecast, by Application

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast, by Application, 2017-2031
    • 9.3.1. Fungal Diseases
    • 9.3.2. Cancer Therapy
    • 9.3.3. Pain Management
    • 9.3.4. Viral Vaccines
    • 9.3.5. Photodynamic Therapy
    • 9.3.6. Others
  • 9.4. Market Attractiveness Analysis, by Application

10. Global Liposome Drug Delivery Market Analysis and Forecast, by End-user

  • 10.1. Introduction & Definition
  • 10.2. Key Findings / Developments
  • 10.3. Market Value Forecast, by End-user, 2017-2031
    • 10.3.1. Hospitals
    • 10.3.2. Specialty Centers
    • 10.3.3. Ambulatory Surgical Centers
    • 10.3.4. Others
  • 10.4. Market Attractiveness Analysis, by End-user

11. Global Liposome Drug Delivery Market Analysis and Forecast, by Region

  • 11.1. Key Findings
  • 11.2. Market Value Forecast, by Region
    • 11.2.1. North America
    • 11.2.2. Europe
    • 11.2.3. Asia Pacific
    • 11.2.4. Latin America
    • 11.2.5. Middle East & Africa
  • 11.3. Market Attractiveness Analysis, by Region

12. North America Liposome Drug Delivery Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Liposome Structure, 2017-2031
    • 12.2.1. Unilamellar Liposomes
      • 12.2.1.1. Small
      • 12.2.1.2. Large
    • 12.2.2. Multilamellar liposomes
    • 12.2.3. Others
  • 12.3. Market Value Forecast, by Product, 2017-2031
    • 12.3.1. Liposomal Doxorubicin
    • 12.3.2. Liposomal Paclitaxel
    • 12.3.3. Liposomal Amphotericin B
    • 12.3.4. Others
  • 12.4. Market Value Forecast, by Technology, 2017-2031
    • 12.4.1. Stealth Liposome Technology
    • 12.4.2. Non PEGylated Liposome Technology
    • 12.4.3. DepoFoam Liposome Technology
    • 12.4.4. Lysolipid Thermally Sensitive Liposome Technology
  • 12.5. Market Value Forecast, by Application, 2017-2031
    • 12.5.1. Fungal Diseases
    • 12.5.2. Cancer Therapy
    • 12.5.3. Pain Management
    • 12.5.4. Viral Vaccines
    • 12.5.5. Photodynamic Therapy
    • 12.5.6. Others
  • 12.6. Market Value Forecast, by End-user, 2017-2031
    • 12.6.1. Hospitals
    • 12.6.2. Specialty Centers
    • 12.6.3. Ambulatory Surgical Centers
    • 12.6.4. Others
  • 12.7. Market Value Forecast, by Country, 2017-2031
    • 12.7.1. U.S.
    • 12.7.2. Canada
  • 12.8. Market Attractiveness Analysis
    • 12.8.1. By Liposome Structure
    • 12.8.2. By Product
    • 12.8.3. By Technology
    • 12.8.4. By Application
    • 12.8.5. By End-user
    • 12.8.6. By Country

13. Europe Liposome Drug Delivery Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Liposome Structure, 2017-2031
    • 13.2.1. Unilamellar Liposomes
      • 13.2.1.1. Small
      • 13.2.1.2. Large
    • 13.2.2. Multilamellar liposomes
    • 13.2.3. Others
  • 13.3. Market Value Forecast, by Product, 2017-2031
    • 13.3.1. Liposomal Doxorubicin
    • 13.3.2. Liposomal Paclitaxel
    • 13.3.3. Liposomal Amphotericin B
    • 13.3.4. Others
  • 13.4. Market Value Forecast, by Technology, 2017-2031
    • 13.4.1. Stealth Liposome Technology
    • 13.4.2. Non PEGylated Liposome Technology
    • 13.4.3. DepoFoam Liposome Technology
    • 13.4.4. Lysolipid Thermally Sensitive Liposome Technology
  • 13.5. Market Value Forecast, by Application, 2017-2031
    • 13.5.1. Fungal Diseases
    • 13.5.2. Cancer Therapy
    • 13.5.3. Pain Management
    • 13.5.4. Viral Vaccines
    • 13.5.5. Photodynamic Therapy
    • 13.5.6. Others
  • 13.6. Market Value Forecast, by End-user, 2017-2031
    • 13.6.1. Hospitals
    • 13.6.2. Specialty Centers
    • 13.6.3. Ambulatory Surgical Centers
    • 13.6.4. Others
  • 13.7. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.7.1. Germany
    • 13.7.2. U.K
    • 13.7.3. France
    • 13.7.4. Italy
    • 13.7.5. Spain
    • 13.7.6. Rest of Europe
  • 13.8. Market Attractiveness Analysis
    • 13.8.1. By Liposome Structure
    • 13.8.2. By Product
    • 13.8.3. By Technology
    • 13.8.4. By Application
    • 13.8.5. By End-user
    • 13.8.6. By Country/Sub-region

14. Asia Pacific Liposome Drug Delivery Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Liposome Structure, 2017-2031
    • 14.2.1. Unilamellar Liposomes
      • 14.2.1.1. Small
      • 14.2.1.2. Large
    • 14.2.2. Multilamellar liposomes
    • 14.2.3. Others
  • 14.3. Market Value Forecast, by Product, 2017-2031
    • 14.3.1. Liposomal Doxorubicin
    • 14.3.2. Liposomal Paclitaxel
    • 14.3.3. Liposomal Amphotericin B
    • 14.3.4. Others
  • 14.4. Market Value Forecast, by Technology, 2017-2031
    • 14.4.1. Stealth Liposome Technology
    • 14.4.2. Non PEGylated Liposome Technology
    • 14.4.3. DepoFoam Liposome Technology
    • 14.4.4. Lysolipid Thermally Sensitive Liposome Technology
  • 14.5. Market Value Forecast, by Application, 2017-2031
    • 14.5.1. Fungal Diseases
    • 14.5.2. Cancer Therapy
    • 14.5.3. Pain Management
    • 14.5.4. Viral Vaccines
    • 14.5.5. Photodynamic Therapy
    • 14.5.6. Others
  • 14.6. Market Value Forecast, by End-user, 2017-2031
    • 14.6.1. Hospitals
    • 14.6.2. Specialty Centers
    • 14.6.3. Ambulatory Surgical Centers
    • 14.6.4. Others
  • 14.7. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.7.1. China
    • 14.7.2. Japan
    • 14.7.3. India
    • 14.7.4. Australia & New Zealand
    • 14.7.5. Rest of Asia Pacific
  • 14.8. Market Attractiveness Analysis
    • 14.8.1. By Liposome Structure
    • 14.8.2. By Product
    • 14.8.3. By Technology
    • 14.8.4. By Application
    • 14.8.5. By End-user
    • 14.8.6. By Country/Sub-region

15. Latin America Liposome Drug Delivery Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Liposome Structure, 2017-2031
    • 15.2.1. Unilamellar Liposomes
      • 15.2.1.1. Small
      • 15.2.1.2. Large
    • 15.2.2. Multilamellar liposomes
    • 15.2.3. Others
  • 15.3. Market Value Forecast, by Product, 2017-2031
    • 15.3.1. Liposomal Doxorubicin
    • 15.3.2. Liposomal Paclitaxel
    • 15.3.3. Liposomal Amphotericin B
    • 15.3.4. Others
  • 15.4. Market Value Forecast, by Technology, 2017-2031
    • 15.4.1. Stealth Liposome Technology
    • 15.4.2. Non PEGylated Liposome Technology
    • 15.4.3. DepoFoam Liposome Technology
    • 15.4.4. Lysolipid Thermally Sensitive Liposome Technology
  • 15.5. Market Value Forecast, by Application, 2017-2031
    • 15.5.1. Fungal Diseases
    • 15.5.2. Cancer Therapy
    • 15.5.3. Pain Management
    • 15.5.4. Viral Vaccines
    • 15.5.5. Photodynamic Therapy
    • 15.5.6. Others
  • 15.6. Market Value Forecast, by End-user, 2017-2031
    • 15.6.1. Hospitals
    • 15.6.2. Specialty Centers
    • 15.6.3. Ambulatory Surgical Centers
    • 15.6.4. Others
  • 15.7. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.7.1. Brazil
    • 15.7.2. Mexico
    • 15.7.3. Rest of Latin America
  • 15.8. Market Attractiveness Analysis
    • 15.8.1. By Liposome Structure
    • 15.8.2. By Product
    • 15.8.3. By Technology
    • 15.8.4. By Application
    • 15.8.5. By End-user
    • 15.8.6. By Country/Sub-region

16. Middle East & Africa Liposome Drug Delivery Market Analysis and Forecast

  • 16.1. Introduction
    • 16.1.1. Key Findings
  • 16.2. Market Value Forecast, by Liposome Structure, 2017-2031
    • 16.2.1. Unilamellar Liposomes
      • 16.2.1.1. Small
      • 16.2.1.2. Large
    • 16.2.2. Multilamellar liposomes
    • 16.2.3. Others
  • 16.3. Market Value Forecast, by Product, 2017-2031
    • 16.3.1. Liposomal Doxorubicin
    • 16.3.2. Liposomal Paclitaxel
    • 16.3.3. Liposomal Amphotericin B
    • 16.3.4. Others
  • 16.4. Market Value Forecast, by Technology, 2017-2031
    • 16.4.1. Stealth Liposome Technology
    • 16.4.2. Non PEGylated Liposome Technology
    • 16.4.3. DepoFoam Liposome Technology
    • 16.4.4. Lysolipid Thermally Sensitive Liposome Technology
  • 16.5. Market Value Forecast, by Application, 2017-2031
    • 16.5.1. Fungal Diseases
    • 16.5.2. Cancer Therapy
    • 16.5.3. Pain Management
    • 16.5.4. Viral Vaccines
    • 16.5.5. Photodynamic Therapy
    • 16.5.6. Others
  • 16.6. Market Value Forecast, by End-user, 2017-2031
    • 16.6.1. Hospitals
    • 16.6.2. Specialty Centers
    • 16.6.3. Ambulatory Surgical Centers
    • 16.6.4. Others
  • 16.7. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 16.7.1. GCC Countries
    • 16.7.2. South Africa
    • 16.7.3. Rest of Middle East & South Africa
  • 16.8. Market Attractiveness Analysis
    • 16.8.1. By Liposome Structure
    • 16.8.2. By Product
    • 16.8.3. By Technology
    • 16.8.4. By Application
    • 16.8.5. By End-user
    • 16.8.6. By Country/Sub-region

17. Competition Landscape

  • 17.1. Market Player - Competition Matrix, by tier and size of companies
  • 17.2. Market Share Analysis, by Company, 2021
  • 17.3. Company Profiles
    • 17.3.1. Johnson & Johnson Services, Inc.
      • 17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.1.2. Product Portfolio
      • 17.3.1.3. Financial Overview
      • 17.3.1.4. SWOT Analysis
      • 17.3.1.5. Strategic Overview
    • 17.3.2. Gilead Sciences, Inc.
      • 17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.2.2. Product Portfolio
      • 17.3.2.3. Financial Overview
      • 17.3.2.4. SWOT Analysis
      • 17.3.2.5. Strategic Overview
    • 17.3.3. Sun Pharmaceutical Industries Ltd.
      • 17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.3.2. Product Portfolio
      • 17.3.3.3. Financial Overview
      • 17.3.3.4. SWOT Analysis
      • 17.3.3.5. Strategic Overview
    • 17.3.4. Novartis AG
      • 17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.4.2. Product Portfolio
      • 17.3.4.3. Financial Overview
      • 17.3.4.4. SWOT Analysis
      • 17.3.4.5. Strategic Overview
    • 17.3.5. Teva Pharmaceutical Industries Ltd
      • 17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.5.2. Product Portfolio
      • 17.3.5.3. Financial Overview
      • 17.3.5.4. SWOT Analysis
      • 17.3.5.5. Strategic Overview
    • 17.3.6. Janssen Pharmaceuticals, Inc.
      • 17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.6.2. Product Portfolio
      • 17.3.6.3. Financial Overview
      • 17.3.6.4. SWOT Analysis
      • 17.3.6.5. Strategic Overview
    • 17.3.7. CELSION Corporation
      • 17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.7.2. Product Portfolio
      • 17.3.7.3. Financial Overview
      • 17.3.7.4. SWOT Analysis
      • 17.3.7.5. Strategic Overview
    • 17.3.8. Abbott
      • 17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.8.2. Product Portfolio
      • 17.3.8.3. Financial Overview
      • 17.3.8.4. SWOT Analysis
      • 17.3.8.5. Strategic Overview
    • 17.3.9. Ipsen Pharma
      • 17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.9.2. Product Portfolio
      • 17.3.9.3. Financial Overview
      • 17.3.9.4. SWOT Analysis
      • 17.3.9.5. Strategic Overview
    • 17.3.10. Spectrum Pharmaceuticals, Inc.
      • 17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.10.2. Product Portfolio
      • 17.3.10.3. Financial Overview
      • 17.3.10.4. SWOT Analysis
      • 17.3.10.5. Strategic Overview
    • 17.3.11. Takeda Pharmaceutical Company Limited
      • 17.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.11.2. Product Portfolio
      • 17.3.11.3. Financial Overview
      • 17.3.11.4. SWOT Analysis
      • 17.3.11.5. Strategic Overview